Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacokinetics, Pharmacodynamics,”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01884935
What this trial is testing

PK and PD Study of Natalizumab in Pediatric Subjects With RRMS

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Biogen 13
Not applicableStudy completedNCT03650140
What this trial is testing

Pharmacokinetics and Pharmacodynamics of Anthocyanins

Who this might be right for
Gout
Rutgers, The State University of New Jersey 10
Early research (Phase 1)Study completedNCT02525679
What this trial is testing

Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 655130 in Healthy Male Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 78
Early research (Phase 1)Study completedNCT00463697
What this trial is testing

Investigate The Effect Of Inhaling A Single Dose Of GW642444M In Asthmatic Patients

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 20
Early research (Phase 1)Study completedNCT04758234
What this trial is testing

LY3549492 in Healthy Participants

Who this might be right for
Healthy
Eli Lilly and Company 54
Early research (Phase 1)Active Not RecruitingNCT07052032
What this trial is testing

An Open-label Study of CND261 in Seropositive Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Candid Therapeutics 47
Testing effectiveness (Phase 2)Study completedNCT01061216
What this trial is testing

Pharmacokinetics/Dynamics of Basal (Continuous) Insulin Infusion Administered Either Intradermally or Subcutaneously

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Becton, Dickinson and Company 20
Early research (Phase 1)Study completedNCT03346330
What this trial is testing

Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), Food-effect of TRK-750

Who this might be right for
Healthy, Peripheral Neuropathic Pain
Toray Industries, Inc 105
Early research (Phase 1)Study completedNCT00754130
What this trial is testing

MK-0941 Multiple Dose Study in Japanese Patients With Type 2 Diabetes (MK-0941-011).

Who this might be right for
Diabetes Mellitus, Non-Insulin-Dependent
Merck Sharp & Dohme LLC 16
Early research (Phase 1)Study completedNCT01784211
What this trial is testing

LY2605541 and Glargine and Exercise in Participants With Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
Eli Lilly and Company 76
Testing effectiveness (Phase 2)Ended earlyNCT01624636
What this trial is testing

Safety and Tolerability of Intravenous LFG316 in Wet Age-related Macular Degeneration (AMD).

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 1
Early research (Phase 1)Study completedNCT04015232
What this trial is testing

Comparative Immunogenicity Study of Multiple Doses of Proposed Pegfilgrastim Biosimilar, INTP5 of Intas Pharmaceuticals Ltd., India Against Neulasta of Amgen Inc., USA in Healthy, Adult Human Subjects.

Who this might be right for
ImmunogenicityHealthy Volunteers
Intas Pharmaceuticals, Ltd. 200
Early research (Phase 1)UnknownNCT05989724
What this trial is testing

A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorBreast CancerPancreatic Cancer+2 more
Qurgen Inc. 150
Testing effectiveness (Phase 2)Study completedNCT00404768
What this trial is testing

The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor

Who this might be right for
Obstetric Labour, Premature
GlaxoSmithKline 93
Testing effectiveness (Phase 2)Study completedNCT01999582
What this trial is testing

Intravenous or Subcutaneous Dosing of Sotatercept (ACE-011) in Patients With End-Stage Kidney Disease on Hemodialysis

Who this might be right for
AnemiaKidney Failure, Chronic
Celgene 50
Early research (Phase 1)Study completedNCT06056024
What this trial is testing

Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and Oesophagus

Who this might be right for
Solid Tumor, KRAS Mutation
Boehringer Ingelheim 47
Testing effectiveness (Phase 2)Looking for participantsNCT05487170
What this trial is testing

RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma (CHAMP-1)

Who this might be right for
Advanced Solid TumorDLBCL
Ranok Therapeutics (Hangzhou) Co., Ltd. 32
Testing effectiveness (Phase 2)Study completedNCT01531777
What this trial is testing

Dose Finding and Pharmacokinetics/Pharmacodynamics Study of Apatinib in the Treatment of Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Jiangsu HengRui Medicine Co., Ltd. 40
Early research (Phase 1)Study completedNCT05576298
What this trial is testing

A Clinical Study Comparing the Pharmacokinetics and Pharmacodynamic Characteristics of Insulin Degludec Injection (RD15003) and Insulin Degludec Injection (Tresiba®) in Healthy Subjects

Who this might be right for
Type 2 Diabetes
Sunshine Lake Pharma Co., Ltd. 46
Early research (Phase 1)Study completedNCT01560481
What this trial is testing

Clinical Trial to Evaluate Safety and pK Profile of Metformin Glycinate in Healthy Volunteers

Who this might be right for
Healthy
Laboratorios Silanes S.A. de C.V. 49
Next Page